(Q37776403)

23 August 2017

1 reference

title

The application of metabonomics to predict drug-induced liver injury (English)

1 reference

23 August 2017

The Application of Metabonomics to Predict Drug-Induced Liver Injury (English)

1 reference

DOI

10.1038/CLPT.2010.151

https://api.crossref.org/works/10.1038/CLPT.2010.151

12 June 2024

main subject

adverse drug reaction

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20668441

12 June 2024

author name string

T. M. O'Connell

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20668441

12 June 2024

P. B. Watkins

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20668441

12 June 2024

language of work or name

English

0 references

publication date

28 July 2010

1 reference

Clinical Pharmacology & Therapeutics

23 August 2017

published in

1 reference

23 August 2017

volume

88

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

394-399

1 reference

Using controlled clinical trials to learn more about acute drug-induced liver injury

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

Monitoring for hepatotoxicity: what is the predictive value of liver "function" tests?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

Biomarkers for the diagnosis and management of drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

HLA-B*5701 screening for hypersensitivity to abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

Metabonomics: a platform for studying drug toxicity and gene function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

Pharmaco-metabonomic phenotyping and personalized drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

The in vivo and in vitro protective properties of taurine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

Evidence of different metabolic phenotypes in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

Human metabolic phenotype diversity and its association with diet and blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

A systems biology approach to understanding elevated serum alanine transaminase levels in a clinical trial with ximelagatran

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

An integrative approach for identifying a metabolic phenotype predictive of individualized pharmacokinetics of tacrolimus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

Clinical pharmacokinetics of tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

Hepatic findings in long-term clinical trials of ximelagatran

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

Glycine protection of PC-12 cells against injury by ATP-depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

Studies of acetaminophen and metabolites in urine and their correlations with toxicity using metabolomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

INTERMAP: background, aims, design, methods, and descriptive statistics (nondietary).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

Higher blood pressure in middle-aged American adults with less education-role of multiple dietary factors: the INTERMAP study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: the INTERMAP study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

Susceptibility of Human Metabolic Phenotypes to Dietary Modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

Individual Human Phenotypes in Metabolic Space and Time

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

Metabonomics, dietary influences and cultural differences: a 1H NMR-based study of urine samples obtained from healthy British and Swedish subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

The correlation between urinary and liver taurine levels and between pre-dose urinary taurine and liver damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

7 January 2021

Role of taurine in preventing acetaminophen-induced hepatic injury in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

7 January 2021

Metabolism and excretion of methylamines in rats

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

7 January 2021

Pharmacometabonomic phenotyping reveals different responses to xenobiotic intervention in rats

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

7 January 2021

Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

7 January 2021

Effect of glycine on valproate toxicity in rat hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

7 January 2021

Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

7 January 2021

Background to the INTERMAP study of nutrients and blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.151

7 January 2021

Identifiers

DOI

10.1038/CLPT.2010.151

1 reference

release_j52x2axkmjeqpkhhthqast2vba

23 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/j52x2axkmjeqpkhhthqast2vba

24 November 2022

mapped directly with Wikidata item

1 reference